Propylthiouracil
Propylthiouracil (PTU) yɛ aduro a wɔde sa hyperthyroidism yadeɛ .[1] This includes hyperthyroidism a Graves' disease ne kɔmpɔ de ba nyinaa no, ɛtumi sa. [1] yeinom pa ho a gye sɛ [1] methimazole, ne oprehyɛn mu na wɔde adi dwuma[1] Ɛyɛ aduro a wɔnom[1]
Nsunsuansoɔ
[sesa]Nsunsuansoɔ no bi ne sɛ, ɛtumi ma obi nnwi so te, ɛtumi ma obi ho keka no, ɛtumi de honamyaw ba, ɛtumi de tipaeɛ, abofono ne ɛfeɛ. Ɛtɔ da mpo a, ɛtumi de berɛboɔ ho haw ba.[1] Ɔpemfoɔ fa a, ɛtumi ha abɔfra a ɔhyɛ ne yam no.[1] Propylthiouracil ka antithyroid nnuro abusuakuo no ho.[2] Ɛkwan a ɛfa so yɛ adwuma ne sɛ, ɛma thyroid hormone a thyroid gland de ma nipadua no so te.[1]
Wɔgyee Propylthiouracil too mu wɔ ayarehwɛ mu wɔ afe Apem, Ahankron ne Aduanan(1940). [3] World Health Organization agye ato mu sɛ ɛka nnuro a ɛho hia pa ara no ho. [4]
Beaeɛ a Menyaa Mmoa Firiiɛ
[sesa]- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 "Propylthiouracil". The American Society of Health-System Pharmacists. Archived from the original on 27 December 2016. Retrieved 8 December 2016.
- ↑ British national formulary : BNF 69 (69 ed.). British Medical Association. 2015. p. 493. ISBN 9780857111562.
- ↑ De Groot LJ, Jameson JL (2010). Endocrinology Adult and Pediatric: The Thyroid Gland (in English). Elsevier Health Sciences. p. e202. ISBN 978-0323221535. Archived from the original on 2016-12-26.
- ↑ World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.